NEOLA Stock Overview
Neola Medical AB (publ) develops medical equipment for continuous monitoring of the lungs of premature babies.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Neola Medical AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | kr1.89 |
52 Week High | kr2.80 |
52 Week Low | kr1.16 |
Beta | 0.93 |
1 Month Change | 2.72% |
3 Month Change | -4.79% |
1 Year Change | 18.13% |
3 Year Change | -56.20% |
5 Year Change | n/a |
Change since IPO | -71.79% |
Recent News & Updates
Recent updates
Shareholder Returns
NEOLA | SE Medical Equipment | SE Market | |
---|---|---|---|
7D | -21.9% | 3.3% | -0.7% |
1Y | 18.1% | -61.4% | 4.4% |
Return vs Industry: NEOLA exceeded the Swedish Medical Equipment industry which returned -7.5% over the past year.
Return vs Market: NEOLA exceeded the Swedish Market which returned 10.3% over the past year.
Price Volatility
NEOLA volatility | |
---|---|
NEOLA Average Weekly Movement | 10.9% |
Medical Equipment Industry Average Movement | 7.2% |
Market Average Movement | 6.1% |
10% most volatile stocks in SE Market | 13.1% |
10% least volatile stocks in SE Market | 3.5% |
Stable Share Price: NEOLA's share price has been volatile over the past 3 months.
Volatility Over Time: NEOLA's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2016 | 7 | Hanna Sjostrom | www.neolamedical.se |
Neola Medical AB (publ) develops medical equipment for continuous monitoring of the lungs of premature babies. It offers neonatal intensive care with NEOLA, a medical device that offer continuous lung monitoring and real-time alerts of life-threatening complications using technology that measures lung volume changes and oxygen gas concentration. NEOLA provides intensive care and healthier lives for preterm born infants.
Neola Medical AB (publ) Fundamentals Summary
NEOLA fundamental statistics | |
---|---|
Market cap | kr132.58m |
Earnings (TTM) | -kr9.01m |
Revenue (TTM) | kr9.83m |
13.5x
P/S Ratio-14.7x
P/E RatioIs NEOLA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
NEOLA income statement (TTM) | |
---|---|
Revenue | kr9.83m |
Cost of Revenue | kr1.77m |
Gross Profit | kr8.06m |
Other Expenses | kr17.07m |
Earnings | -kr9.01m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.13 |
Gross Margin | 82.04% |
Net Profit Margin | -91.70% |
Debt/Equity Ratio | 0% |
How did NEOLA perform over the long term?
See historical performance and comparison